Illinois
Prescription drug spending and prescribing in Illinois, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $9.6B for prescriptions written in Illinois, the 9th most of 52 states and territories, and 3.2% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $9.6B
- Medicaid drugs, 2025: $3.3B
- Opioid share of claims: 3.2%
- Life-science raises, 2 years: $566M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Illinois | United States | Difference |
|---|---|---|---|
| Opioids | 3.2% | 3.5% | -11% |
| Antibiotics | 4.4% | 4.4% | +1% |
| Antipsychotics | 1.8% | 1.7% | +5% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Illinois's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Hepatitis A And B Vaccine/Pf | 3.6× | 37,343 |
| Varicella-Zoster Ge/As01b/Pf | 2.8× | 384,829 |
| Rsvpref3 Antigen/As01e/Pf | 2.7× | 270,032 |
| Diphth,pertuss(Acell),tet Vac | 2.6× | 138,937 |
| Sodium Chloride/Nahco3/Kcl/Peg | 2.4× | 30,813 |
| Rsv Vacc, Pref A And Pref B/Pf | 2.2× | 128,191 |
| Enalapril Maleate | 1.9× | 136,628 |
| Cefadroxil | 1.8× | 34,108 |
| Insulin Aspart (Niacinamide) | 1.8× | 30,342 |
| Enoxaparin Sodium | 1.7× | 32,428 |
Biggest Medicaid Drugs
What Illinois's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
60 Form D raises by companies based in Illinois in the last two years; the 10 largest. See all raises- Pathos AI, Inc.$283M · Biotech · May 1, 2025
- HOPSCOTCH HEALTH HOLDINGS, LLC$38M · Other health care · Apr 21, 2026
- KeyCare, Inc.$28M · Other health care · Apr 17, 2025
- Cardiosense, Inc.$26M · Other health care · Aug 24, 2026
- Avenacy Inc.$26M · Pharma · Nov 26, 2024
- HOPSCOTCH HEALTH HOLDINGS, LLC$17M · Other health care · Sep 16, 2025
- HelloJoy, Inc.$15M · Other health care · Jul 2, 2025
- Amphix Bio, Inc.$10M · Biotech · Dec 19, 2025
- Pharmazz, Inc.$10M · Pharma · Jun 11, 2025
- Pinch Med, Inc.$9M · Other health care · May 23, 2025
State Attorney General Health-Care Cases
Antitrust cases Illinois joined, newest first; see every case- United States and Plaintiff States v. UnitedHealth et al. (D. Md. 1:24-cv-03267-JKB)2025 · Final judgment
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)2020 · Final judgment
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- People ex rel. Madigan v. Carle Clinic Association, P.C., No. 07h115 (Champaign Cty. 6th Jud. Dist. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG